The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advance the use of digitally measured nocturnal scratch as a meaningful endpoint for atopic dermatitis. These tools, along with DiMe’s previous work to support digital clinical measures, lay the groundwork for future use of the measure in clinical research, technology development, and reimbursement decisions—thereby furthering dermatology research and improving the lives of AD patients and caregivers. Jennifer Goldsack, DiME CEO, and Lucy Cesnakova, a program lead at DiMe, discuss their work and its impact on the field. Listen now.